pharma · Prostate cancer
Curium Pharma
Curium Romania S.R.L.
Curium Romania S.R.L is a pharma organization headquartered in EU. Primary therapeutic focus areas include Prostate cancer. NovaPharmaNews links 3 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this en
Boston, USA HQ
2017 Founded
2,181 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2017
- Employees
- 2,181
- Programs
- 3
- Drugs
- 0
- Patents
- 0
64Cu-PSMA I&T
Phase 3 · small molecule · Prostate cancer
64Cu-PSMA I&T for Prostate cancer is a Phase 3 program (small_molecule) at Curium Romania S.R.L. with 1 ClinicalTrials.gov record(s).
Internal code CURCu64PSM0003
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Curium Romania S.R.L.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Prostate cancer
- Status
- active
- Trials
- 1